Dow Up0.36% Nasdaq Up0.12%

Keryx Biopharmaceuticals Inc. (KERX)

-NasdaqCM
15.63 Down 0.55(3.40%) Aug 21, 4:00PM EDT
|After Hours : 15.63 Down 0.00 (0.02%) Aug 21, 4:56PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue -   10,000   -   -  
Cost of Revenue -   -   -   -  
Gross Profit -   10,000   -   -  
Operating Expenses
Research Development11,079  15,555  8,863  9,917  
Selling General and Administrative11,464  8,096  8,876  5,815  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (22,543) (13,651) (17,739) (15,732)
Income from Continuing Operations
Total Other Income/Expenses Net129  121  71  81  
Earnings Before Interest And Taxes(22,414)(13,530)(17,668)(15,651)
Interest Expense -   -   -   -  
Income Before Tax(22,414)(13,530)(17,668)(15,651)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(22,414)(13,530)(17,668)(15,651)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (22,414) (13,530) (17,668) (15,651)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (22,414) (13,530) (17,668) (15,651)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.